Research Papers:
Folate metabolism genetic polymorphisms and meningioma and glioma susceptibility in adults
Metrics: PDF 1654 views | HTML 2529 views | ?
Abstract
Dongming Chen1,*, Jun Dong1,*, Ying Huang2,*, Feng Gao1, Xiaopeng Yang1, Xianglun Gong1, Xiaochen Lv3, Chenghao Chu4, Yonggang Wu1 and Yong Zheng5
1Neurosurgery Department, People’s Hospital of Xinjiang Uyghur Autonomous Region, Urumqi 830001, Xinjiang, China
2Respiratory Department, People’s Hospital of Xinjiang Uyghur Autonomous Region, Urumqi 830001, Xinjiang, China
3Nursing College of Xinjiang Medical University, Urumqi 830001, Xinjiang, China
4Tumor Hospital of Xinjiang Medical University, Urumqi 830001, Xinjiang, China
5Neurosurgery Department, The Eighth People’s Hospital of Shenzhen, Shenzhen 518101, Guangdong, China
*These authors have contributed equally to this work
Correspondence to:
Yong Zheng, email: [email protected]
Yonggang Wu, email: [email protected]
Keywords: glioma, meningioma, MTHFR, MTRR, SNP: meta-analysis
Received: November 15, 2016 Accepted: June 01, 2017 Published: July 04, 2017
ABSTRACT
Polymorphic variants of genes involved in folate metabolism are implicated in the susceptibility to meningioma and glioma, but the results from published articles are controversial and inconclusive. Therefore, we performed this meta-analysis including all studies available to evaluate the relationship between folate metabolism genetic polymorphisms and the susceptibility to meningioma and glioma in adults. We searched the literature in PubMed, EMBASE and Cochrane Central Library for relevant articles published up to August 2016. The odds ratios (ORs) and the corresponding 95% confidence intervals (95%Cls) were used to evaluate the associations of two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) with the risk of meningioma and glioma in adults. We found significant association of MTHFR A1298C (rs1801131) variant genotypes with increased incidence of meningioma and glioma in this study population (CA vs. AA: OR=1.22, P<0.001; CA+CC vs. AA: OR=1.18, P=0.002). Moreover, we found that MTRR A66G (rs1801394) variant genotypes was associated with increased risk of meningioma and glioma (G vs. A: OR=1.11, P=0.020; GG vs. AA+AG: OR=1.17, P=0.043; GG vs. AA: OR=1.22, P=0.023). In conclusion, our meta-analysis suggests that two folate metabolism genetic variants MTRR A66G (rs1801394) and MTHFR A1298C (rs1801131) contribute to genetic susceptibility to meningioma and glioma in adults.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18986